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A novel idea is emerging that a large molecular repertoire is common to the nervous and immune systems, which might
reflect the existence of novel neuronal functions for immune molecules in the brain. Here, we show that the transmem-
brane adaptor signaling protein CD3, first described in the immune system, has a previously uncharacterized role in
regulating neuronal development. Biochemical and immunohistochemical analyses of the rat brain and cultured neurons
showed that CD3 is mainly expressed in neurons. Distribution of CD3 in developing cultured hippocampal neurons, as
determined by immunofluorescence, indicates that CD3 is preferentially associated with the somatodendritic compart-
ment as soon as the dendrites initiate their differentiation. At this stage, CD3 was selectively concentrated at dendritic
filopodia and growth cones, actin-rich structures involved in neurite growth and patterning. siRNA-mediated knockdown
of CD3 in cultured neurons or overexpression of a loss-of-function CD3 mutant lacking the tyrosine phosphorylation
sites in the immunoreceptor tyrosine-based activation motifs (ITAMs) increased dendritic arborization. Conversely,
activation of endogenous CD3 by a CD3 antibody reduced the size of the dendritic arbor. Altogether, our findings reveal
a novel role for CD3 in the nervous system, suggesting its contribution to dendrite development through ITAM-based
mechanisms.
INTRODUCTION
Neuronal communication requires the formation of neuro-
nal circuitry, achieved by a coordinated development of
axons and dendrites. The ability of dendrites to receive and
process neuronal signals is greatly determined by the den-
dritic architecture elaborated during development. It is now
well established that dendrite formation is regulated by
multiple factors that precisely control the extent of dendritic
outgrowth and branching. Neuronal activity (Lohmann et al.,
2002), diffusible cues such as semaphorins and Slits (Polleux
et al., 2000; Whitford et al., 2002), and intracellular signaling
molecules (Fink et al., 2003) have all been shown to regulate
various steps of dendrite development. Interestingly, a large
number of the aforementioned factors are also involved in
the differentiation and function of other cell types in the
immune system. For example, semaphorins and Slits are
required for the maturation, migration, and activation of T
lymphocytes and dendritic cells (Wu et al., 2001; Kumano-
goh and Kikutani, 2003). This common molecular repertoire
shared by different biological systems emphasizes the exis-
tence of similar mechanisms underlying fundamental func-
tions in cell differentiation, maturation and activation. Con-
versely, the expression and the role of several proteins
thought to be specific for the immune system have recently
been extended to the CNS (Boulanger and Shatz, 2004). This
is the case for the CD3 subunit CD3, a transmembrane
adaptor signaling protein only characterized to date in T
lymphocytes and natural killer (NK) cells, which associates
to different cell surface receptors depending on the cell type
(Lanier, 2001; Pitcher and van Oers, 2003). In T-cells, CD3 is
a component of the CD3 complex, the signaling module of
the T-cell receptor (TCR) that recognizes peptide fragments
presented by major histocompatibility complex (MHC) mol-
ecules and is thus responsible for antigenic recognition
(Samelson et al., 1985). CD3 is instrumental in these pro-
cesses because it is required for receptor-mediated signal
transduction through its three copies of immunoreceptor
tyrosine-based activation motif (ITAM; Pitcher and van
Oers, 2003). Moreover, CD3 also participates in intrathymic
T-cell differentiation, which is arrested in mice lacking CD3
(Malissen et al., 1993). Brain analysis of these CD3-deficient
mice showed a striking abnormal development of the reti-
nogeniculate projections in the visual system (Huh et al.,
2000). Defects in synaptic plasticity recorded in the hip-
pocampus were also observed with an enhanced LTP and a
lack of LTD (Huh et al., 2000; Barco et al., 2005). These
findings suggest a novel role for CD3 in the development of
the nervous system as well as in synaptic functions. How-
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ever, the cerebral expression of CD3 proteins and the iden-
tity of CD3-expressing cells have yet to be elucidated. In
this study, we show that CD3 is predominantly expressed
in neurons where it selectively localized at dendritic growth
cones and filopodia. CD3 loss-of-function experiments in
cultured neurons increased dendritic arborization, whereas
activating endogenous CD3 inhibited dendritic branching.
Altogether, our findings reveal a novel role for CD3 in the
nervous system, highlighting its contribution to neuronal
development.
MATERIALS AND METHODS
All protocols were carried out in accordance with French standard ethical
guidelines for laboratory animals (Agreement 75-669).
Antibodies
Two commercially available anti-CD3 affinity-purified rabbit polyclonal an-
tibodies were used for CD3 immunodetection. The first antibody (Ab36) was
raised against aa 36–54, corresponding to an intracellular sequence of the
protein (Spring Bioscience, Fremont, CA). The second antibody (Ab22) was
raised against aa 22–30, a sequence corresponding to the N-terminus extra-
cellular region of the protein (Alexis Bioscience, San Diego, CA). The mouse
monoclonal antibodies to tau (antibody tau-1, clone PC1C6), microtubule-
associated protein 2 (MAP2, clone AP20), neuronal nuclei (NeuN), and glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH; clone 6C5) were pur-
chased from Chemicon (Billerica, MA). The mouse monoclonal -tubulin
isotype III antibody (Tuj1, clone SDL.3D10) and the mouse monoclonal anti-
glial fibrillary acidic protein (GFAP) were obtained from Sigma (St. Louis,
MO) and the rabbit polyclonal tau from Dako (Glostrup, Denmark). The
mouse monoclonal anti-oligodendrocyte (RIP) was purchased from Develop-
mental Studies Hybridoma Bank (University of Iowa, Iowa City, IA) and
anti-CD90 (clone OX7) was purchased from Bioatlantic (Nantes, France). The
mouse anti-CD11b/c (clone OX42) and anti-CD161 (clone 3.2.3) were pro-
duced in our laboratory from hybridomas obtained from the European Col-
lection of Animal Cell Culture (Salisbury, United Kingdom). The mouse mAb
anti-CD45 receptor (CD45R, clone HIS24) was purchased from BD Biosciences
(San Jose, CA). Peroxidase-conjugated goat anti-rabbit and biotinylated- and
fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit secondary
antibodies were purchased from Jackson Laboratory (Bar Harbor, ME). The
aminomethylcoumarin acetate (AMCA)-conjugated streptavidin was obtained
from Beckman Coulter (Fullerton, CA) and the Alexa Fluor 568 goat anti-rabbit
and goat anti-mouse were obtained from Invitrogen (Carlsbad, CA)
PCR Analysis
Total RNA was extracted from 50 to 100 mg of rat brain and spleen by
homogenization in 1 ml of Trizol reagent (Invitrogen, Carlsbad, CA) for 5 min
at room temperature followed by chloroform extraction and isopropanol
precipitation. After centrifugation and washing in ethanol, RNA was resus-
pended in water and frozen at20°C until use. After Turbo DNAse treatment
(Invitrogen), 2 g of RNA were reverse-transcribed with a MMLV-reverse
transcriptase system (Invitrogen). The synthesized cDNA was denatured for
2 min at 92°C, and 100 ng was subjected to 35 cycles of PCR amplification
(92°C for 30s, 60°C for 30s, 72°C for 1 min, and a final extension step at 72°C
for 5 min) in a total volume of 25 l containing 0.4 M of sense and antisense
primers, 0.5 U of Taq polymerase (Invitrogen), and 200 M of dNTP. For the
amplification of CD3 mRNA, the sense oligonucleotide primer was 5TC-
GAGGAATTCCCACCATGAAGTGGACGGCATCAGTC-3 and the anti-
sense oligonucleotide primer was 5-TGACGACCGGTGCGCGAGGGGGC-
AGGGTCTG-3, giving rise to a 152-base pair fragment. Internal standards
were generated by amplifying the hypoxanthine-guanine phosphoribosyl-
transferase (HPRT) mRNA using the following set of primers: sense, 5-
TTCCTCCTCAGACCGCTTTT-3 and antisense, 3-CTTATAGCCCCCCT-
TCAGCA-5, giving rise to a 262-base pair amplification product. PCR
products were loaded on a 2% agarose gel.
Slice Preparation
Adult male Sprague-Dawley rats weighing 200 g were deeply anesthetized
with Rompun-ketamine (1:4) at 1 ml/kg (i.p.). They were then perfused
transcardially with 250 ml of 4% paraformaldehyde (PFA) in phosphate-
buffered saline (PBS). Brains were dissected and postfixed in the same solu-
tion for 1 h at room temperature and then were cryoprotected overnight at
4°C in a solution of 15% sucrose in PBS and then 48 h at 4°C in 30% sucrose
in PBS. Coronal sections (30 m thick) were cut on a cryostat and collected in
0.1 M phosphate buffer (PB), pH 7.4.
Cell Cultures
COS-7 cells were grown in DMEM containing 10% fetal calf serum (FCS), 100
g/ml streptomycin, and 100 U/ml penicillin.
Neural stem cell cultures were prepared from whole brains of E15 rat
embryos as previously described (Sergent-Tanguy et al., 2006). Briefly, tissues
freed of meninges were incubated with 0.25% trypsin for 15 min at 37°C, and
after addition of 10% FCS and 10 mg/ml DNAse I, were dissociated by
mechanical trituration. Aggregates were removed by decantation and cells
were further purified from small debris by centrifugation. The cell suspension
was then incubated for 12 h in basal culture medium composed of DMEM
containing Hams’ F12 (1/1, vol/vol), 3 mM glucose, 5 mM HEPES (pH 7.2),
100 g/ml streptomycin, and 100 U/ml penicillin (basal medium) and sup-
plemented with 10% FCS (complete medium), and the uncoated cells were
transferred to basal medium supplemented with N2 (Invitrogen) and 10
ng/ml FGF-2 to allow for the formation of neurospheres. After 5 d of culture,
neurospheres were dissociated by trypsin and mechanical trituration to give
a single-cell suspension. This was then plated on poly-l-ornithine–coated
glass coverslips at a density of 3  104 cells/cm2 for 2 h in complete medium
and subsequently fixed in 4% PFA and 4% sucrose in PBS.
Glia cultures were prepared from newborn rat forebrains. Briefly, cortexes
were dissected and dissociated by trypsin and DNAse and the cells were
plated at a density of 35  103 cells/cm2 in MEM containing 10% FCS, 0.6%
d-glucose, 100 g/ml streptomycin, and 100 U/ml penicillin. The medium
was replaced with serum-free MEM containing N2 supplements 24 h before
the neuron culture.
Rat hippocampal and cortical cultures were prepared from 18-d-old rat
embryos by previously described methods (Goslin et al., 1998; Pujol et al.,
2005). Briefly, hippocampi were dissected and dissociated by trypsin and
trituration and plated on glass coverslips coated with poly-l-lysine. For
calcium imaging assays and transfection, cells were plated at a density of 18
103 cells/cm2. For all other uses, cells were plated at 4  103 cells/cm2. The
cells were allowed to attach on coverslips before being transferred to a dish
containing a glial feeder layer, prepared as described above, and maintained
for up to 21 d in serum-free MEM with N2 supplements. Neurons were used
for immunocytochemical staining and morphology analysis 3 h after plating
or after 1, 2, 4, 7, 10, and 21 d in vitro (DIV). For Western blot analysis, cells
were collected at 7 DIV.
Western Blot Analysis
For Western blot analysis, homogenates from CD3-transfected COS-7 cells, 7
DIV cultured neurons, T lymphocytes, and rat forebrain and spleen were
prepared. Briefly, cultured neurons and COS-7 cells were scraped into PBS
containing a cocktail of protease inhibitors and were then pelleted and resus-
pended in Laemmli buffer. T lymphocytes were isolated from total spleno-
cytes after nylon wool adherence and depletion of CD161 (NK cells), CD11b/c
(monocytes), and CD45R (B lymphocytes) positive cells using magnetic beads
(Invitrogen/Dynal, Carlsbad, CA). For tissue preparation, rat forebrains and
spleens were homogenized using a glass Teflon homogenizer in 10 mM
Tris-HCl, pH 7.4, containing 320 mM sucrose and a cocktail of protease
inhibitors. The resulting suspension was centrifuged at 700  g for 10 min.
The supernatant was collected and centrifuged at 150,000  g for 30 min, and
the pellet was resuspended in 10 mM Tris-HCl, pH 7.4. The membrane
preparation was solubilized in Laemmli buffer.
Cell suspensions (500,000 cells) and tissue homogenates (30 g of protein)
were loaded on an SDS-PAGE (12% acrylamide) and transferred to a nitro-
cellulose membrane. The membrane was blocked with 5% dried milk in 20
mM Tris-HCl, pH 7.4, containing 0.45 M NaCl and 0.1% Tween 20 (TBST). The
membrane was then incubated overnight in Ab36 CD3 antibody (2.5 g/ml)
or with anti-GAPDH antibody (0,2 g/ml), diluted in TBST containing 5%
dehydrated milk, washed with TBST, incubated for 1 h in peroxidase-conju-
gated goat anti-rabbit antibody (1:3000) or in peroxidase-conjugated donkey
anti-mouse antibody (1:2000), respectively, and visualized using a chemilu-
minescent substrate (Pierce, Rockford, IL) and exposure to x-ray films.
Immunostaining
For immunohistochemistry on rat brain sections, sections were first incubated
in 0.3% H2O2 in 0.1 M PB for 30 min and, after two washes in PB, were
additionally incubated for 30 min in 3% normal donkey serum (NDS) in PB.
After two washes in PB, sections were incubated overnight at 4°C with Ab36
(0.2 g/ml) or Ab22 (5 g/ml) CD3 antibodies diluted in PB containing 3%
NDS and 0.05% Triton X-100. The following day, sections were washed twice
in PB and incubated for 45 min in biotinylated goat anti-rabbit IgG diluted at
1:200 in PB containing 0.5% NDS, followed by 45 min in streptavidin-biotine
peroxidase solution (ABC Vectastain, Vector Laboratories, Burlingame, CA).
After several rinses in PB, sections were further incubated in 0.05% 3,3dia-
minobenzidine (Vector Laboratories) for 10 min at room temperature and
were then mounted on gelatin-coated slides, dehydrated in graded ethanol,
delipidated in xylene, cover-slipped with Eukit, and examined with a Zeiss
microscope (Thornwood, NY). For control experiments, the primary antibod-
ies were omitted during the procedure. For double immunofluorescence
labeling, sections were incubated overnight at 4°C with Ab36 CD3 antibody
and either anti-GFAP (1:500), anti-NeuN (1:200), anti-CD11b/c (1:500), or
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anti-RIP (1:500) antibodies diluted in PB containing 3% NDS and 0.05% Triton
X-100. Slices were then incubated for 1 h with the appropriate FITC- or Alexa
Fluor 568–conjugated secondary antibodies (1:200 and 1:1000, respectively)
and mounted with Vectashield (Vector Laboratories) on glass slides for anal-
ysis on an Axioskop 2 plus microscope (Zeiss). Pictures were acquired with
10 and 20 objectives using a digital camera (AxioCam HRC, Zeiss) driven
by AxioVision Release 4.2 software. Two animals were analyzed to determine
the phenotype of CD3-expressing cells in the brain. For each animal, the
number of CD3-positive cells was recorded in the neocortex from two slices
(300 CD3-positive cells per slice), and the number of CD3-positive cells that
were also immunoreactive for GFAP (astrocyte), NeuN (neuron), CD11b/c
(microglia), or RIP (oligodendrocytes) was counted. Images for presentation
were prepared for printing with Adobe Photoshop (San Jose, CA). For neural
stem cells and cultured neurons, cells were fixed in 4% PFA for 15 min,
permeabilized for 5 min in 0.25% Triton X-100 in PBS, and incubated for 30
min in 10% bovine serum albumin (BSA) in PBS at 37°C. Cells were then
incubated overnight in Ab36 CD3 antibody (2.5 g/ml) or CD90 antibody (3
g/ml) diluted in PBS containing 3% BSA. For double labeling, Ab36 CD3
antibody was mixed with either MAP2 (1:200), tau-1 (1:500), or Tuj1 (1:1000)
antibodies. F-actin was labeled with TRITC-phalloidin (1:10000, Sigma Al-
drich) for 1 h at 37°C before immunostaining. Cells were then incubated with
the appropriate secondary antibodies conjugated to FITC, biotin (1:200), or
Alexa Fluor 568 (1:1000). When the biotin-conjugated antibody was used, cells
were subsequently incubated in AMCA-conjugated streptavidin (1:200). For
double labeling on brain sections or cultured cells, control experiments
achieved by omitting one of the primary antibodies showed the lack of
cross-reactivity between the secondary antibodies and the absence of signal
spillover between the two channels. The coverslips were mounted with
Vectashield on glass slides for analysis on an Axioskop 2 plus microscope
(Zeiss). Pictures were acquired with 20 and 63 objectives using a digital
camera as described above.
DNA Constructs and Small Interfering RNA
A plasmid encoding rat CD3 fused at the C terminus with enhanced green
fluorescent protein (EGFP) was produced. The coding sequence of CD3
containing a Kozak sequence at the 5 end was obtained by PCR amplification
and subcloned in frame into the EcoRI-AgeI sites of pEGFP-N1 to generate the
CD3-GFP expression plasmid.
To generate a mutant form of CD3 with the six tyrosine residues substi-
tuted by phenylalanine in the three ITAMs, 100 ng of the following three
primers bearing the mutations—5-AACCAGCTCTTTAACGAGCTCAAT-
CTAGGGCGAAGAGAGGAATTTGATGTTTTG-3, (5-AAGGCGTGTTCA-
ATGCACTGCAGAAAGACAAGATGGCAGAGGCCTTCAGTGAGATT-3,
and (5-ACGGCCTTTTCCAGGGTCTCAGCACTGCCACCAAGGACACCT-
TTGACGCCCTG-3—were mixed with 100 ng of CD3-GFP DNA template.
The reaction was performed using the QuickChange Multi Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA) according to the manufacturer’s
instructions. All the CD3 cDNA constructs were confirmed by sequencing.
For small interfering RNA (siRNA) experiments, four sense and antisense
oligonucleotides corresponding to the following cDNA sequences were pur-
chased from Ambion (Austin, TX): 5-GCAAAAUUCAGCAGGAGUGtt-3
and 5-CACUCCUGCUGAAUUUUGCtc-3, siRNA1, nucleotides 276–294;
5-GCUCUAUAACGAGCUCAAUtt-3 and 5-AUUGAGCUCGUUAUA-
GAGCtg-3; siRNA2, nucleotides 329–347; 5-GGUAACAUGUAAUUAG-
GUCtt-3 and 5-GACCUAAUUACAUGUUACCtt-3, siRNA3, nucleotides
1066–1084; and 5-GGCGUGUACAAUGCACUGCtt and 5-GCAGUG-
CAUUGUACACGCCtt; siRNA4, nucleotides 444–462). A control siRNA
(Ambion), which showed no homology to any known gene sequences from
rat, mouse, or human, was used as a negative control.
Transfections and Pharmacological Treatments
Transfection of COS-7 cells with the CD3-expressing plasmid pRZ-3 (Itoh et
al., 1993) was performed using the Lipofectamine 2000 reagent (Invitrogen) as
previously described (Baudouin et al., 2006). To determine which siRNA was
the most effective in reducing CD3 protein expression, COS-7 cells were
cotransfected with 3 g of pRZ-3 and 50 nM of either siRNA1, 2, 3, or 4 or
negative control using the Lipofectamine 2000 reagent. One day after trans-
fection, cells were collected to analyze CD3 protein expression by Western
blot.
Neuron transfection was performed at 3 DIV with 3 g of either CD3-GFP
cDNA or 3 g of CD3-6Y6F-GFP or 3 g of membrane-targeted GFP
(mGFP) cDNA [GAP-GFP(S65T), a gift from Dr. K. Moriyoshi, Kyoto Univer-
sity, Japan; Moriyoshi et al., 1996], using 3 l of the Lipofectamine 2000
reagent. The cells were fixed in 4% PFA and 4% sucrose in PBS at 5 DIV for
MAP2 and tau double labeling.
For siRNA assays, neurons were cotransfected at 3 DIV with 3 g of mGFP
cDNA and 50 nM of siRNA1 or siRNA3 using 3 l of the Lipofectamine 2000
reagent. The cells were fixed in 4% PFA and 4% sucrose in PBS at 5 DIV for
MAP2 and CD3 double immunolabeling.
For antibody treatments, either 5 g/ml Ab22 CD3 antibody or 5 g/ml
control antibody to human CD16 (3g8) were added to neuron cultures at 1
and 3 DIV. In control cultures the same volume of vehicle was added. Cells
were fixed in 4% PFA and 4% sucrose in PBS at 5 DIV and were immunola-
beled for MAP2 morphological analysis.
To assess the effects of inhibiting protein kinases on CD3 distribution,
neurons were treated at 7 DIV for 5, 15, 30, 60, and 120 min with 10 M
piceatannol (Sigma) an inhibitor of the Syk/ZAP70 family of the protein
tyrosine kinases, 100 nM damnacanthal (Calbiochem, San Diego, CA) a spe-
cific inhibitor of lck, a protein tyrosine kinase of the Src family, 1 M PP2
(Sigma), a broad inhibitor of the Src-family protein tyrosine kinases (Sigma),
or 50 nM wortmannin (Sigma), an inhibitor of phosphoinositide 3-kinase. All
the kinases inhibitors were added directly to the culture medium from a
concentrated DMSO stock. To test the role of the actin cytoskeleton on CD3
localization, neurons were treated for 30 min and 3 and 24 h with 1 M
cytochalasin D (Sigma) added to the culture medium from a concentrated
DMSO stock.
Quantification of CD3 Expression and Neuronal
Morphology Analysis
To quantify CD3 or GAPDH expression in CD3-expressing COS-7 cells after
siRNA transfection, the signal intensity obtained on Western blot membranes
was measured from four experiments using Image J software (http://rsb.in-
fo.nih.gov/ij/) and expressed as a percentage of the intensity obtained from
control cells without siRNA. To quantify CD3 immunoreactivity in neurons
after siRNA transfections, coverslips were scanned on the microscope with a
10 lens and pictures of transfected cell were acquired with a 40 objective.
The intensity of CD3 immunofluorescence was measured with the Image J
software in well-isolated GFP-positive neurons cotransfected with either con-
trol or CD3 siRNAs and in nontransfected neurons located nearby the
transfected cells. The intensity of CD3 immunoreactivity was measured in
the dendritic field, but excluding the cell body, because CD3 was mainly
targeted to dendrites and because the thickness of the cell body is a frequent
source of nonspecific labeling compared with the nerve processes. A total of
16–34 cells per experimental condition were analyzed from two independent
experiments. For each individual experiment, 3–7 cells were scored from at
least two coverslips. Results are presented as average  SEM of the ratio of
anti-CD3 fluorescence intensity in GFP-positive neurons relative to nearby
nontransfected neurons.
To analyze the morphology of neurons transfected with control siRNA,
siRNA1, siRNA3, mGFP, CD3-GFP, or CD3-6Y6F-GFP, each coverslip was
systematically scanned with a 10 lens and acquired with a 40 or 63 objec-
tive. Images from mGFP-labeled neurons were projected on the computer screen,
all primary dendritic branches were traced with the mouse using the ImageJ
software program, and the number and length of dendritic branches were scored.
As defined in previous studies using a model of hippocampal neuron culture,
protrusions with a length 10 m likely corresponded to filopodia and
dendritic spines, whereas protrusions with a length 10 m were defined as
dendritic branches (Jaworski et al., 2005; Terry-Lorenzo et al., 2005). Conse-
quently, only the protrusions with a length 10 m were taken into account
to quantify the number and length of dendritic branches. Between 10 and 15
cells were scored from at least two coverslips for each experimental condition.
A total of 29–63 cells were analyzed for each experimental condition from
two to four independent experiments, and the data were presented as aver-
age  SEM. To analyze experiments involving neuron cultures treated with
either 3g8 or CD3 antibody, images from MAP2-labeled neurons were ran-
domly acquired with a 20 and 40 lens, and the number and length of
dendritic branches was measured as above. Data are presented as average 
SEM of a total of 40–52 cells per experimental condition recorded from two to
four coverslips (5–10 cells per coverslips) obtained from two to three inde-
pendent neuron cultures. Data analysis was performed using Excel (Mi-
crosoft, Redmond, WA) and GraphPad Prism 4 (San Diego, CA), and statis-
tical analyses were done by Student’s t test. Images were processed and
prepared for printing using Adobe Photoshop.
Fluorescence Measurements of Intracellular Calcium
The effects of Ab22 CD3 antibody on intracellular calcium concentration
([Ca2]i) in 7 DIV cultured neurons were assessed using the calcium-sensitive
fluorescent probe Fluo-3 AM (Molecular Probes). Neurons were loaded with
4 M Fluo-3 AM in Tyrode (145 mM NaCl, 4 mM KCl, 1 mM MgCl2, 1 mM
CaCl2, 5 mM HEPES, and 5 mM glucose) and 0.02% Pluronic at 37°C for 30
min. The coverslips were mounted on the stage of an inverted microscope
(Nikon Diaphot, Tokyo, Japan) equipped for fluorescence and illuminated at
450–490 nm. The emitted light (515 nm) was collected by a high-resolution
image intensifier coupled to a video camera (Extended ISIS camera system;
Photonic Science, Roberts-bridge, United Kingdom) and connected to a digital
image processing board controlled by FLUO software (Imstar, Paris, France).
Cells were maintained at 37°C and continuously superfused with Ca2-free
Tyrode. A microperfusion system allowed for local application and rapid
change of the different experimental media. Microperfusion solutions were
identical to the Ca2-free Tyrode except that they contained 20 mM mannitol
for efficient local perfusion of the neurons under analysis. Single-cell fluores-
cence intensity was measured from digital image processing and displayed
against time. Fluorescence intensity was normalized to the intensity measured
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before antibody application. Calcium variations were quantified by a linear
regression of the first 10 points of the fluorescence curve after antibody
application (	F/F/t in s1).
RESULTS
Expression of CD3 in the Rat Brain and in Cultured
Neurons
To examine whether CD3 mRNA was expressed in the
brain, RT-PCR amplifications of CD3 was performed on
total RNA extracted from rat forebrain and compared with
the spleen. Amplification of HPRT transcripts served as an
internal control to confirm RNA integrity for each prepara-
tion. In brain samples, a band of the expected size of 152
base pairs was detected, although exhibiting a lower inten-
sity than in spleen preparations (Figure 1A). The expression
of CD3 at the protein level was investigated by Western
blot experiments under nonreducing conditions to preserve
the disulfide bridge of the homodimer forms of CD3 known
to be prevalent in immune cells (Baniyash, 2004). Western
blots of COS-7 cells transfected with rat CD3 cDNA showed
that the Ab36 CD3 antibody yielded a single band of 32
kDa, whereas no signal was apparent in nontransfected cells
(Figure 1B). In the spleen, T-cells and cultured neurons, the
32-kDa form was also detected, whereas a 36-kDa band was
present in rat brain homogenates (Figure 1B), a molecular
weight in agreement with the 37-kDa form of CD3 reported
in hippocampus preparations (Sourial-Bassillious et al.,
2006). The characterization of the molecular forms of CD3
expressed in heterologous COS-7 cell systems, splenocytes,
and peripheral T-cells have been well established, which
showed that the nonphosphorylated CD3 homodimer ex-
hibited an apparent molecular weight of 32 kDa and that
activation-induced tyrosine phosphorylation of the ITAMs
resulted in the appearance of multiple forms with molecular
weights ranging from 36 to 45 kDa depending on the num-
ber of phosphorylated tyrosine residues (Sancho et al., 1993;
Furukawa et al., 1994; Garcia and Miller, 1997; van Oers et al.,
2000). Although the 32-kDa form of CD3 detected in CD3-
transfected COS-7 cells, spleen, T-cells, and cultured neu-
rons likely corresponds to a nonphosphorylated CD3 ho-
modimer, the 36-kDa band detected in the brain might
reflect the existence of a constitutively phosphorylated form
of CD3 in cerebral tissue.
We next examined the expression pattern of CD3 protein
in rat brain slices by immunohistochemistry with the anti-
CD3 antibodies Ab36 and Ab22. Using both antibodies,
CD3 immunoreactivity was widely distributed in numer-
ous brain areas, including the cerebral cortex and hippocam-
pus (Figure 2, A–F). Importantly, the distribution of CD3
immunoreactivity displayed by Ab36 strongly paralleled
that obtained with Ab22, both at regional and cellular levels,
supporting the specificity of the immunolabeling produced
by both antibodies (compare Figure 2, B–E, with Figure 2,
B–E). CD3 immunolabeling was extensively associated
with neurons, as assessed by double labeling with the neu-
ronal marker NeuN (Figure 2G) and was shown to outline
the periphery of cell bodies and to be associated with den-
dritic processes (Figure 2, C, C, and F). The phenotype of
CD3-expressing cells in brain slices was further analyzed in
the neocortex by counting the number of CD3-positive cells
that were also immunoreactive for NeuN (neuron), RIP (ol-
igodendrocyte), or GFAP (astrocyte), or CD11b/c (micro-
glia). The quantification indicated that 91  2 and 4  1% of
the total CD3-expressing cells (n 
 1200 from two rats)
were associated with neurons or oligodendrocytes, respec-
tively (Figure 2, G and H). The remaining was associated
with unidentified profiles. Conversely, 88  5% of neurons
(n 
 1300) and 44  6% of oligodendrocytes (n 
 117) were
immunopositive for CD3. No labeling was observed within
astrocytes and microglia (Figure 2, I and J). Altogether, the
biochemical and immunostaining data obtained with the
Ab36 and Ab22 antibodies are consistent with a prominent
constitutive neuronal expression of CD3 in the brain and in
cultured neurons.
CD3 Is Selectively Enriched at Growth Cones and
Filopodia during Neuronal Development
All of the following immunostaining experiments were per-
formed with Ab36 CD3 antibody. To determine at which
stage of neuronal development CD3 started to be ex-
pressed, we first used primary cultures of neural precursor
cells grown as neurospheres, a free-floating cellular aggre-
gate formed of neural stem cells (Reynolds et al., 1992). After
dissociation of the neurospheres into a single cell suspension
and plating onto glass coverslips, neural stem cells initiated
their differentiation to generate neuronal and glial cells. This
culture system allowed to obtain neuroblasts at a very im-
mature stage, only a few hours after the initiation of their
differentiation from neural stem cells. Two hours after plat-
ing, cells were double-labeled with Ab36 CD3 antibody and
a tubulin  III (Tuj1) antibody used as a neuronal marker
(Figure 3A). At this stage, 12  1% of total cells (n 
 346
cells) were immunopositive for Tuj1, and 72.5  6.4% of
Tuj1-positive cells (n 
 43) were also immunolabeled for
CD3. Conversely, all of the CD3-immunopositive cells
were additionally immunopositive for Tuj1, indicating that
CD3 was specifically expressed in newly differentiated neu-
rons. Within these cells, CD3 immunoreactivity was mostly
associated with the periphery of the cell, suggestive of a
plasma membrane localization (Figure 3A).
To study the developmental pattern of CD3 distribution
in neurons, we chose a low-density hippocampal neuron
culture model for which the critical developmental stages
have been well characterized (Dotti et al., 1988). At 1 DIV, a
stage corresponding to the emergence of few minor neurites
and preceding the axonal polarization (stage 2; Dotti et al.,
1988), CD3 immunoreactivity was highly concentrated at
the tip of growing neurites, closely associated with growth
cones (Figure 3B). We found that 92  3% of the neurites
exhibited CD3 immunoreactivity at their tips (74 neurites
Figure 1. Expression of CD3 in the rat brain and in cultured
neurons. (A) Expression of CD3 mRNA in the rat brain. PCR
amplification of CD3 mRNA extracted from adult rat brain and
spleen (positive control). HPRT amplification products indicated
that PCR was performed on comparable levels of RNA. (B) Identi-
fication of heterologously expressed and endogenous CD3 by
Western blot. Cell homogenates of nontransfected (COS-WT) and
CD3-transfected (COS-CD3) COS-7 cells, as well as membrane
homogenates prepared from rat spleen, brain, 7 DIV cultured neu-
rons, and T-cells were resolved on a 12% SDS-PAGE and immuno-
blotted with Ab36 CD3 antibody. An immunoreactive band can be
observed at 32 kDa in CD3-transfected COS-7 cells, spleen, cul-
tured neurons, and T-cells and at 36 kDa in brain homogenates.
Molecular weight markers are indicated on the right.
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analyzed from 18 cells). At 2 DIV, a stage of selective axon
elongation in which the longest neurite corresponds to the
growing axon (stage 3; Dotti et al., 1988), CD3 was still
accumulated at the tip of the processes, with equal distribu-
tion observed for axons and minor neurites (Figure 3C). In
addition, high CD3 immunoreactivity was also detected
within small nascent protrusions localized along neurites,
corresponding to potential future ramifications (Figure 3C).
At 4–5 DIV, characterized by continuing axonal growth and
differentiation of minor neurites into dendrites (stage 4;
Dotti et al., 1988), CD3 distribution was similar to that
observed at 2 DIV, with a further specific enrichment of
CD3 immunoreactivity at the tips of processes. Neverthe-
less, unlike at 2 DIV, at 4–5 DIV CD3 showed a marked
preferential localization with dendrites than with axons
(Figure 3D), as confirmed by double-labeling experiments of
CD3 with the dendritic marker MAP2 and the axonal
marker tau-1 (Figure 4, A and B). Although CD3 immuno-
reactivity was observed in the somatodendritic domain of
virtually all neurons, only a few immunopositive axons
were detected. By 7–10 DIV (stage 5; Dotti et al., 1988), which
is marked by continued maturation of axonal and dendritic
arbors, CD3 immunoreactivity was still highly compart-
mentalized at the tips of dendrites, and profusely associated
with filopodia and spine-like protrusions of the somatoden-
dritic domain (Figure 3, E and E). At 21 DIV, when neurons
have reached a mature stage characterized by the formation
of synaptic contacts, CD3 immunoreactivity was distrib-
uted in clusters that largely overlapped with the postsynap-
tic marker PSD-95 (Figure 3, F and F). However, not all, but
a subset of PSD95-expressing synapses was immunopositive
for CD3, and conversely a fraction of CD3z clusters were
colocalized with PSD-95 (Figure 3F). To examine in detail
the CD3 cellular distribution within growth cones in young
neurons, double-staining experiments on 3 DIV neurons
were performed with Ab36 CD3 antibody and either
TRITC-phalloidin or anti-tubulin  III antibody, to visualize
the respective F-actin– and microtubule-rich regions of the
growth cone (Figure 4, C and D). CD3 immunoreactivity
largely overlapped with the actin meshwork concentrated in
the peripheral region of the growth cone, but was only
rarely associated with the extending filopodia (Figure 4C).
The central region, characterized by bundles of microtubules
was mostly devoid of CD3 labeling (Figure 4D). Altogether,
analysis of the developmental pattern of CD3 immunore-
activity in cultured neurons showed that it is expressed
early during neuron differentiation and is associated with
growth cones and filopodial protrusions throughout devel-
opment. As the neurons mature, CD3 immunoreactivity
becomes mainly restricted to the somatodendritic compart-
ment where it is enriched at synaptic sites.
CD3 Clustering at the Tips of Neurites Is Dependent on
Filamentous Actin and Protein Tyrosine Kinases of the
Syk/ZAP-70 Family
Because CD3 was associated with F-actin–rich regions, we
tested the role of actin filaments in localizing CD3 at
growth cones and filopodia. Neurons were treated with 1
M cytochalasin D for 24 h to disrupt actin microfilaments
and were subsequently immunostained for CD3. This ma-
Figure 2. Distribution of CD3 immunoreactivity in the rat brain. (A) In the parietal cortex, CD3-immunoreactive cells are detected
throughout the six layers, but immunolabeled neuronal processes predominate in layers V and VI. (B–E) The comparison between the
distribution of CD3 immunoreactivity in rat brain slices as revealed by Ab36 (B–E) and Ab22 (B–E) antibodies. Both antibodies give rise
to a virtually identical labeling pattern, as shown here in the cerebral cortex (B, B, C, and C) and hippocampus (D, D, E, and E). At high
magnification in the cerebral cortex (C and C) and in the dentate gyrus of the hippocampus immunolabeled with Ab36 (F), most
CD3-expressing cells exhibit a neuronal morphology and are immunolabeled within both perikarya (arrows in C, C, and F) and dendritic
processes (arrowheads in C, C, and F). (G–J) Double immunolabeling of hippocampal sections with Ab36 CD3 antibody (green) and the
markers (red) NeuN for neurons (G), RIP for oligodendrocytes (H), GFAP for astrocytes (I), and CD11b/c for microglia (J). Scale bars, (A)
300 m; (B and E) 75 m; (C, F, and G–J) 15 m; (D) 1 mm.
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nipulation caused a pronounced redistribution of CD3 in
numerous small puncta dispersed along dendrites but no
longer concentrated at dendritic tips or filopodia (Figure
5A). Interestingly, the dispersed CD3 clusters remained
highly associated with the translocated F-actin puncta, sug-
gesting a close molecular interaction between CD3 and
actin filaments (Figure 5B). Cytochalasin D treatment did
not affect the distribution of Thy-1 (other name CD90), a
GPI-linked membrane protein expressed on neurons in the
nervous system (Morris, 1985; Mahanthappa and Patterson,
1992), suggesting that cytochalasin D did not cause a general
remodeling of the neuronal plasma membrane that would
affect the distribution of all membrane-associated proteins
(Figure 5B). The cytochalasin D–induced redistribution of
CD3 was significantly reversed after 3 h of cytochalasin D
washout (Figure 5A), supporting a major role of actin in the
dynamic regulation of CD3 clustering in and out of neurite
endings and filopodia.
In immune cells, protein tyrosine kinases of the Syk/
ZAP-70 family play a crucial role in the function of CD3 by
regulating its association with effector molecules (Chan et al.,
1994). Considering the close relationships between the phos-
phorylation-regulated activation of signaling molecules and
their subcellular distribution, we investigated whether inhi-
bition of Syk/ZAP-70 kinases would affect CD3 accumula-
tion at growth cones and filopodia. Neurons at 7 DIV were
treated from 5 min to 2 h with 10 M piceatannol to inhibit
Syk/ZAP-70, and CD3 distribution was studied by immu-
nofluorescence. As of 5 min of piceatannol treatment, the
CD3 immunoreactive clusters were completely dispersed,
and a decrease in the overall staining intensity of CD3 was
observed (Figure 5C). The piceatannol-induced CD3 dis-
persal was significantly reversible after 4 h of washout.
Although the main action attributed to piceatannol is to
inhibit Syk/ZAP-70 kinases, a few studies have reported
that piceatannol might also inhibit the Src protein tyrosine
kinase lck (Geahlen and McLaughlin, 1989). We thus tested
whether a global inhibition the Src protein tyrosine kinases
family (including lck) with 1 M PP2 (Figure 5C) or a
selective inhibition of lck with 100 nM damnacanthal, would
affect CD3 distribution similarly as piceatannol. As another
control, neurons were also treated with the phosphoinosi-
tide 3-kinase inhibitor wortmannin (50 nM). No modifica-
tion of CD3 distribution was noticed upon PP2, damnacan-
thal, or wortmannin treatments compared with untreated
neurons at any of the time points examined (from 5 min to
2 h). These data suggest that phosphorylation events medi-
Figure 3. Developmental distribution of
CD3 in neurons derived from neural stem
cells and in hippocampal neurons in culture
from 1 to 21 DIV. (A) Neural stem cells cul-
tured as neurospheres were dissociated,
plated on glass coverslips, and fixed 2 h later
in PFA for the immunodetection of CD3 and
Tuj1 (Tubulin  III), used as a neuronal
marker. The immunopositive CD3 cells are
all immunoreactive for Tuj1 (arrows), corre-
sponding to newly differentiated neurons.
(B–E) Hippocampal neuron cultures were
fixed at 1 (B), 2 (C), 4 (D), 7 (E), and 21 (F) DIV
and were immunolabeled for CD3. From 1–7
DIV, the paired phase-contrast image is shown
to visualize cell morphology. At 1 and 2 DIV
(B and C), CD3 immunoreactivity is selec-
tively associated with minor neurite endings,
axonal growth cones (arrowhead in C), and
protrusions emerging along the growing axon
(arrows in C). At 4 DIV (D), CD3 immunore-
activity is highly enriched at the tips of den-
drites and short branches. At 7 DIV (E) CD3
immunoreactivity is still observed at the tip of
dendrites and branches and is also abundantly
associated with filopodia and spine-like pro-
trusions distributed along dendritic processes,
as shown at higher magnification of the boxed
region (E). (F) Neurons at 21 DIV were fixed
and immunolabeled for CD3 (green) and the
postsynaptic marker PSD-95 (red). Numerous
CD3 clusters are distributed along dendritic
processes that partially colocalized with
PSD-95 at synaptic sites as shown at higher
magnification of the boxed region (F). Scale
bars, (A and B) 5 m; (C) 10 m; (D–F) 15 m.
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Figure 4. CD3 is concentrated at dendritic tips
and filopodia and is selectively associated with the
peripheral region of the growth cone. (A) Neurons at
7 DIV were fixed and immunolabeled for CD3
(green) and the dendritic marker MAP2 (red). CD3-
immunoreactivity is mostly confined to the somato-
dendritic compartment and is not detected in the
axon, defined as a MAP2-negative process (arrows).
(B) Double labeling of CD3 (green) and the axonal
marker tau-1 (red) of 7 DIV neurons show that the
axonal trunk and growth cone (arrow) are devoid of
CD3 immunoreactivity. (C) At growth cones of 2–3
DIV neurons, CD3 immunoreactivity (green) is lo-
calized to the peripheral actin-rich region labeled
with TRITC-phalloidin (red), but is mostly excluded
from the extending filopodia. (D) The central region
of the growth cone, defined as a microtubule-rich
region immunolabeled with Tuj1 antibody (red), is
devoid of CD3 immunoreactivity. Scale bars, (A
and B) 20 m; (C and D) 2.5 m.
Figure 5. The selective concentration of CD3 at
dendritic tips depends on filamentous actin and on
protein tyrosine kinases of the Syk/ZAP-70 family.
(A) Neurons at 7 DIV were either left untreated
(control) or were exposed for 24 h to 1 M of cy-
tochalasin D to depolymerize actin (cyto D), and
fixed and immunolabeled for CD3 (green) and
MAP2 (red). Cytochalasin D treatment induced a
redistribution of the large CD3 clusters localized at
dendritic tips to small puncta dispersed along den-
drites, whereas MAP2 immunostaining was unaf-
fected. A 3-h washout after cytochalasin D treatment
resulted in significant reversal that shows reaccumu-
lation of CD3 at dendritic tips (3-h washout). (B)
Control neurons and cytochalasin D–treated neu-
rons are double-labeled for either CD3 or CD90
(green) and for F-actin with TRITC-phalloidin (red).
In control neurons CD3 strictly colocalizes to F-
actin–rich subdomains identified as filopodia and
dendritic tips. In cytochalasin-treated neurons, CD3
remains associated to the dispersed F-actin puncta,
which become evenly distributed within dendrites.
The distribution of CD90 shows no relationship with
F-actin labeling in control neurons and is unaffected
by the cytochalasin D treatment. (C) Neurons at 7
DIV were either left untreated (control) or treated for
5 min with 10 M piceatannol, an inhibitor of the
protein tyrosine kinases of the Syk/ZAP-70 family,
and were then immunolabeled for CD3 (green) and
MAP2 (red). Blockade of the Syk/ZAP-70 kinases
induces a rapid loss of CD3 aggregates, an effect
reversed after 4 h of washout. By contrast, CD3
distribution was unaffected by 1 M PP2, an inhib-
itor of the Src-family of protein tyrosine kinases.
Scale bars, (A and C) 20 m; (B) 2 m.
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ated by protein tyrosine kinases of the Syk/ZAP-70 family
play a major role in regulating CD3 distribution in neurons.
CD3 siRNA and a CD3 Mutant Lacking the Sites of Tyr
Phosphorylation Impairs Dendrite Formation
On the basis of our finding that CD3 proteins are specifi-
cally enriched at dendritic tips and protrusions during the
stage of dendrite elaboration and maturation, we examined
whether CD3 might play a role in dendrite development.
For this purpose, we used an siRNA approach to knock-
down CD3 protein expression in cortical neurons culture.
Four CD3 siRNA sequences against different regions of
CD3 were tested for their efficacy and specificity in sup-
pressing CD3 expression in CD3-transfected COS-7 cells
(Figure 6A). We found by immunoblot analysis that two of
them, siRNA1 and siRNA3, caused a marked reduction of
the CD3 protein expression reaching 30.7  6.1 and 7.5 
5.2%, respectively, of the signal intensity of CD3-expressing
cells transfected with a control siRNA (Figure 6A). To test
whether these siRNAs can decrease the expression level of
endogenous CD3 in neurons, cultured neurons at 3 DIV
were cotransfected with either siRNA1 or siRNA3 and
mGFP as a marker of transfection, and CD3 immunoreac-
tivity was quantified in the dendritic arbor at 5 DIV. The
addition of siRNA1 or siRNA3 induced a severe reduction of
endogenous CD3 level that dropped to 21.7 6.0% (n
 23)
and 14.5 5.1% (n
 16), respectively, of the averaged CD3
signal intensity measured in nearby untransfected neurons
(Figure 6, B and C). The control siRNA did not affect CD3
immunostaining as compared with neighboring untrans-
fected cells (98.7  14.8%, n 
 34; Figure 6, B and C). The
siRNA transfections were performed at 3 DIV, and the cells
were analyzed at 5 DIV, a period corresponding to a stage of
dendrite differentiation in this neuronal culture model (Dotti et
al., 1988). Therefore, these experiments allowed us to test the
contribution of CD3 to dendrite formation. We observed that
CD3 siRNA1 and siRNA3 significantly increased the size and
the complexity of the dendritic arbor analyzed after immuno-
staining for CD3 and the dendritic marker MAP2. The total
length of dendritic branches recorded per cell was increased by
90 and 123% upon transfection with siRNA1 or siRNA3, re-
spectively, compared with control cells transfected with a con-
trol siRNA (control siRNA, 86.5 11.1 m, n
 63 cells; CD3
siRNA1, 163.3  16.3 m, n 
 52 cells, p  0.001; CD3
siRNA3, 192.6 31.6m, n
 29 cells, p 0.01, Student’s t test;
Figure 6, C–E). Moreover, the amount of dendritic branching
recorded per cell was increased by 80 and 99% after transfec-
tion with CD3 siRNA1 or siRNA3, respectively, compared
with siRNA control cells (control siRNA, 2.94  0.34, n 
 63
cells; CD3 siRNA1, 5.29  0.45, n 
 52 cells, p  0.001; CD3
siRNA3, 5.86  0.89, n 
 29 cells, p  0.01; Figure 6, C–E).
There was no detectable difference in the dendritic arbor be-
tween either siRNA1 and siRNA3 (p 
 0.43 for the branching
length and p 
 0.57 for the dendritic branchpoint number) or
between mGFP and control siRNA (p
 0.63 for the branching
length and p 
 0.60 for the dendritic branchpoint number;
values for mGFP are 79.1  10.5 m for the branching length,
n 
 56 cells, and 2.70  0.31 for the number of dendritic
branches, n
 56 cells), supporting that the changes in dendritic
morphology induced by CD3-targeted siRNAs were specifi-
cally linked to the reduced CD3 expression.
To further test the role of CD3 in dendrite outgrowth, we
generated a putative dominant negative form of CD3. In T
lymphocytes, CD3 is the critical signaling subunit of the
TCR-CD3 complex involved in the recognition of MHC-
peptide complex present on antigen-presenting cells. The
function of CD3 critically depends on its 3 ITAMs, a se-
quence motif containing two Tyr phosphorylation sites
(YxxLx(6–8)YxxL). On TCR-MHC binding, Src family pro-
tein tyrosine kinases Lck or Fyn phosphorylates the Tyr
residues in the ITAMs, triggering the T-cell response. Sub-
stitution of the six Tyr into Phe residues completely abol-
ished the ability of CD3 to be phosphorylated and therefore
converts CD3 into an inactive form (Lowin-Kropf et al.,
1998; van Oers et al., 2000). We thus replaced the six Tyr of
CD3 fused to GFP (CD3-GFP) by Phe and the resulting
CD3-6Y6F-GFP construct was overexpressed in cultured
neurons by transfection at 3 DIV. Neurons were transfected
with mGFP alone as control. Cells were fixed at 5 DIV and
immunostained for MAP2 to label dendrites. In neurons
overexpressing the CD3-6Y6F-GFP mutant, the dendrites
were more elaborate than in the mGFP-transfected cells
(Figure 7). Quantification revealed that the total branch
length recorded per cell and branchpoint number per cell
increased by 65 and 42%, respectively (for total branch
length per cell, mGFP, 79.1  10.5 m, n 
 56 cells; CD3-
6Y6F-GFP, 130.9  18.8 m, n 
 32 cells, p  0.01; for
number of branchpoint per cell, mGFP, 2.70  0.31, n 
 56
cells; CD3-6Y6F-GFP, 3.84  0.46, n 
 32 cells, p  0.05;
Figure 7). Thus, expression of CD3-6Y6F-GFP affected den-
dritic development by promoting branchpoint formation,
suggesting that CD3 may be normally involved in dendrite
patterning, likely through an ITAM-based mechanism. Con-
versely, transfection with CD3-GFP induced a reduction in
the length and number of dendritic branches recorded per
cell by 34% (52.5  6.8 m, n 
 58 cells, p  0.05) and 27%
(1.97  0.20, n 
 58 cells, p 
 0.051), respectively, compared
with control cells transfected with mGFP (see values above;
Figure 7). This result suggests that endogenous CD3 activ-
ity was limiting in dendrite patterning and that increasing
CD3 concentration through neuron transfection with CD3-
GFP further inhibited dendrite development. Altogether,
these results suggest that neuronal CD3 is a negative reg-
ulator of dendrite outgrowth and patterning.
Application of CD3 Antibody to Cultured Neurons Elicits
Intracellular Calcium Increase and Inhibits Dendrite
Development
If CD3 is a negative regulator of dendrite development,
then activating endogenous protein should impair dendrite
formation. We used a CD3 antibody targeted to the short
extracellular domain of the molecule (antibody Ab22) as a
tool that might potentially activate cell surface CD3. Initial
characterization of the intracellular signaling mediated by
CD3 in leukocytes relied on the use of chimeric receptors
comprising a heterologous cell-surface molecule fused to the
cytoplasmic tail of CD3 (Irving and Weiss, 1991; Letourneur
and Klausner, 1991). Application of antibodies to the cell
surface of these chimeric receptors recapitulated the signal
transduction events normally elicited by the intact TCR-CD3
receptor complex that leads to Ca2 mobilization (Wange
and Samelson, 1996). We applied a similar strategy with
CD3 Ab22 antibody to measure Ca2 mobilization by flu-
orescent Ca2 imaging on live neurons. It is important to
note that these experiments were carried out in the absence
of the glial feeder layer, thus enabling measurement of direct
effects of CD3 antibody on hippocampal neurons, because
the low-density culture system we used represents a virtu-
ally pure neuron culture model (Goslin et al., 1998). Exper-
iments were performed in the absence of external Ca2 to
measure the release of Ca2 from internal compartments.
Application of 5 g/ml control antibody (3g8) targeted to
the extracellular sequence of the human transmembrane
protein CD16 for 10 min did not affect the [Ca2]i level
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Figure 6. CD3 siRNA1 and siRNA3 promoted dendritic branching. (A) The efficacy and specificity of CD3 siRNA was tested in
CD3-transfected COS-7 cells by immunoblot analysis. An equal amount of protein was loaded for each lane, and the same samples were
blotted against CD3 and GAPDH antibodies. CD3 siRNA1 and siRNA3 induced a strong suppression of CD3 expression. The signal
intensity for each CD3 siRNA is plotted below as a percent of the signal intensity obtained from control CD3-expressing COS-7 cells without
siRNA. The data are expressed as mean SEM from four experiments (* p 0.05 compared with cells transfected with CD3 plasmid alone).
(B) Quantification of CD3 expression in cultured cortical neurons transfected at 3 DIV and immunostained at 5 DIV. Data are presented as
a ratio of anti-CD3 fluorescence intensity in mGFP-positive cells relative to nearby nontransfected cells  SEM (for each condition n  15
cells from at least two cultures; *** p  0.001). (C) Knockdown of neuronal CD3 expression by siRNA1 and siRNA3. Neurons were
cotransfected at 3 DIV with mGFP (green) and either control siRNA or CD3 siRNA1 or siRNA3, and were immunolabeled at 5 DIV for CD3
(red) and the dendritic marker MAP2 (blue). Neurons transfected with a control siRNA show a robust CD3 immunoreactivity on dendrites
(arrowheads). Neurons transfected with either CD3 siRNA1 or siRNA3 show a decreased CD3 immunoreactivity in dendrites (arrows) and
a more complex dendritic arbor compared with control cells. (D) mGFP-labeled cultured cortical neurons transfected at 3 DIV and fixed at
5 DIV sampled from cultures transfected with mGFP alone, or mGFP control siRNA, or mGFP CD3 siRNA1, or mGFP CD3 siRNA3.
(E) Quantification of the total length and number of dendritic branches per cell. Data are presented as mean  SEM of 29–63 cells from two
to four independent cultures. ** p  0.01, *** p  0.001 (Student’s t test) compared with corresponding measurements in cells cotransfected
with mGFP and the control siRNA. Scale bar, 20 m.
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(Figure 8A). By contrast, the subsequent application of Ab22
CD3 antibody at 5 g/ml onto the same cells induced a
rapid rise of [Ca2]i in 87% of the neurons (46/53 recorded
cells from three experiments; Figure 8A), indicating that
CD3 Ab22 antibody induced a Ca2 release from internal
stores, likely through a direct binding to cell surface-associ-
ated CD3 proteins. These data suggest that Ab22 exhibits
agonist-like activity and activates endogenous CD3 trigger-
ing a [Ca2]i increase. We thus applied CD3 Ab22 antibody
to neuron culture to analyze the effects of endogenous CD3
recruitment on dendrite patterning. The CD3 antibody (5
g/ml) was added at 1 and 3 DIV, and the cells were fixed
at 5 DIV for MAP2 immunostaining followed by dendrite
morphology analysis. The control cultures consisted in the
addition of either the vehicle alone or the control antibody
3g8. No difference was observed in the dendritic arbor be-
tween the vehicle- and 3g8-treated neurons (for total branch
length, vehicle-treated cells, 46.7  7.6 m, n 
 52 cells,
control antibody treated-cells, 52.0  9.1 m, n 
 40 cells;
p 
 0.65; for branchpoint number, vehicle-treated cells,
1.71 0.21, n
 52 cells control antibody treated-cells, 1.83
0.23, n 
 40 cells, p 
 0.72; Figure 8, B and C). By contrast,
substantial modifications of the dendritic profile were ob-
served after CD3 Ab22 application. Both the total branch
length and the number of branchpoints per cell were de-
creased by 78 and 67%, respectively, compared with control
3g8-treated cells (for total branch length per cell, 11.3  2.3
m, n
 50 cells, p 0.001; for branchpoint number per cell,
0.60  0.12, p  0.001; Figure 8, B and C). Collectively, our
data suggest that activating endogenous CD3 inhibits den-
drite development in young neurons.
DISCUSSION
A novel idea is emerging that a large molecular repertoire is
common to the nervous and immune systems, which might
reflect the existence of neuronal functions for molecules
originally characterized in the immune system. Alterna-
tively, such converging repertoire might also reflect physi-
ological interactions between the two systems (Boulanger
and Shatz, 2004; Steinman, 2004). Here, we show that the
signaling adaptor protein CD3, first described in the im-
mune system (Samelson et al., 1985), has a previously un-
characterized role in regulating neuronal development.
CD3 distribution in developing neurons showed a selective
association with dendritic filopodia and growth cones, actin-
rich structures involved in neurite growth and patterning.
Loss-of-function experiments by siRNA-mediated knock-
down or by overexpression of CD3 mutated in its three
ITAMs affected dendrite formation with an increased num-
ber and length of dendritic branching. Conversely, overex-
pressing CD3 or activating endogenous CD3 by a CD3
antibody reduced the length and number of dendritic
branches. Altogether, our findings reveal a novel role for
CD3 in the nervous system, highlighting its contribution to
dendrite development through an ITAM-based mechanism.
Neuronal Expression of CD3 and Its Selective
Association with Growth Cones and Filopodia in
Young Neurons
We provide biochemical and immunohistochemical evi-
dence for the expression of CD3 in the CNS. Previous
studies reported the detection of CD3 mRNA in feline and
mouse brain sections (Corriveau et al., 1998; Huh et al., 2000),
but our study is the first to demonstrate expression of CD3
protein in brain slices and to identify the CD3-expressing
cells, which were predominantly neurons and to a lesser
extent oligodendrocytes. The cellular distribution of CD3
immunoreactivity analyzed in developing hippocampal
neurons showed a prominent enrichment at dendritic
growth cones and filopodia in young neurons and at den-
dritic spines in mature neurons. These aforementioned neu-
ronal subdomains are all actin-rich structures, and we in-
deed found in young neurons a striking colocalization of
CD3 with F-actin. Treatment with the actin depolymeriza-
tion agent cytochalasin D caused a dispersal of CD3 clus-
Figure 7. Overexpression of a CD3 mutant lack-
ing the Tyr phosphorylation sites in the ITAMs in-
creased dendritic branching. Neurons transfected at
3 DIV with mGFP or CD3-GFP or CD3-6Y6F-GFP
were fixed at 5 DIV and were visualized by the GFP
signal. The dendritic arborization was increased in
neurons expressing CD3-6Y6F-GFP but reduced in
neurons expressing CD3-GFP compared with con-
trol neurons transfected with mGFP. The length and
number of dendritic branches were measured and
data are expressed as the mean SEM of 32–58 cells
from three independent experiments (bottom right).
* p  0.05 ,** p  0.01 (Student’s t test) compared
with corresponding measurements in cells trans-
fected with mGFP. Scale bar, 15 m.
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ters, indicating that the accumulation of CD3 at growth
cones and filopodia was dependent on F-actin. Interestingly,
CD3 remained colocalized with F-actin puncta spread
throughout the neuropile upon actin disruption, suggesting
a close molecular interaction between CD3 and F-actin.
Association of CD3 with the actin cytoskeleton has been
reported in lymphocytes and proposed to play a role in the
dynamic rearrangements of the actin cytoskeleton required
for the formation and stabilization of the immunological
synapse at the interface between antigen-presenting cells
and T lymphocytes (Caplan et al., 1995; Rozdzial et al., 1995;
Krummel and Davis, 2002). In neurons, the localization of
CD3 at cytoskeletal F-actin–rich structures positions it ide-
ally for a role in the regulation of dendritic shaping driven
by actin-based mechanisms. CD3 could directly bind actin
filaments to regulate actin network assembly or act as an
adaptor molecule that would connect membrane receptors
and signaling proteins linked to the assembly/stability of
actin cytoskeleton. In the latter case, one possibility is that
the effects of CD3 recruitment on neuronal morphogenesis
involves the actin-related RhoA GTPase, which has been
documented to inhibit dendritic growth and branch exten-
sion (Li et al., 2000; Wong et al., 2000).
Novel Function of CD3 in Dendrite Patterning
Our finding that CD3 was enriched at dendritic growth
cones and filopodia in young neurons suggests a potential
role for this molecule in dendrite morphogenesis. Accord-
ingly, the inhibition of CD3 expression in cultured neurons
by siRNA increased dendrite outgrowth, a phenotype sim-
ilarly obtained by expression of a CD3 mutant lacking the
Tyr phosphorylation sites within the ITAMs. The effects of
the CD3-6Y6F-GFP mutant were likely due to the compe-
tition with the endogenous protein and suggest that the role
of CD3 on dendritic shaping required tyrosine-based sig-
naling motifs. Conversely, CD3 overexpression, which pre-
sumably mimicked an increased recruitment of the protein,
and CD3 antibody application, which acts through the ac-
tivation of endogenously expressed CD3, both reduced the
length and number of dendritic branches. Together, these
data suggest that CD3 acts as a negative regulator of den-
dritic arbor complexity through an ITAM-based mecha-
nisms.
A critical role for CD3 in the establishment of the neuro-
nal network has been described in the retinogeniculate pro-
jections of the visual system (Huh et al., 2000). In mice
lacking CD3, the area of retinal projections in the lateral
geniculate nucleus is abnormally larger and ectopic clusters
of inputs were observed, indicating that CD3 is required to
precisely restrict the field of retinal projections (Huh et al.,
2000). The fact that CD3 mRNA was detected in the lateral
geniculate nucleus suggests a postsynaptic expression of
CD3 proteins in this area (Huh et al., 2000). In light of our
results, one could hypothesize that CD3 deletion might
result in an excessive dendritic arborization of lateral genic-
ulate nucleus neurons, which in turn might induce a broader
extension of axonal inputs, as observed in mutant mice.
Potential Mechanisms for CD3 Neuronal Function
In T-cell, CD3 is a component of the CD3 complex that also
includes CD3, -, and - subunits. The CD3, - and - have
all been detected in the cerebellum and CD3-deficient mice,
in which CD3- and CD3- protein levels are also reduced,
showed an impaired neuronal architecture of Purkinje neu-
rons (Nakamura et al., 2007). The cerebral expression of the
four CD3 subunits raised the possibility that a kind of CD3
complex may exist in the brain similarly as in the immune
system. However, CD3 mRNA was not detected in the
cerebellum (Nakamura et al., 2007), and we were not able to
detect CD3 at the protein level in forebrain samples (data
not shown). Thus CD3 appeared to be expressed in distinct
brain regions different from those for CD3, -, and -,
suggesting that CD3 may function independently from the
other CD3 subunits, as reported in NK cells (Lanier, 2001).
One major issue that still needs to be resolved is the identi-
fication of the CD3-bearing neuronal receptor, which could
be either a known immune or neuronal receptor. Several
CD3-containing receptors have been identified in the im-
mune system in both T-cells and NK cells. The most docu-
mented is the TCR in T-cells, which interacts with peptide-
MHC complexes present on target cells (Samelson, 2002).
The mRNA for the  subunit of the TCR has been detected
in the murine CNS, but the absence of genomic recombina-
tion and the failure to detect the corresponding protein in
brain homogenates make it unlikely to be the neuronal
CD3-containing receptor (Syken and Shatz, 2003; Nishiyori
Figure 8. Application of CD3 antibody to hippocampal cultured
neurons induces an intracellular calcium increase and reduces the
complexity of the dendritic arbor. (A) Cultured neurons at 7 DIV
were loaded with Fluo-3 AM and exposed sequentially to the con-
trol antibody 3g8 (5 g/ml) and to the CD3 Ab22 antibody (5
g/ml). Left, representative relative fluo-3 fluorescence in response
to 3g8 and CD3 antibodies shows a rise in [Ca2]i after CD3
antibody application. [Ca2]i increase was observed in 46 of 53
neurons from three different cultures. Right, bar graph comparing
the slope of fluorescence increase triggered by 3g8 and CD3 anti-
bodies. (B) MAP2-immunolabeled 5 DIV hippocampal neurons
sampled from cultures treated with a control antibody (control) or
with CD3 Ab22 antibody (CD3 antibody). (C) The length and
number of dendritic branches were measured on neurons immuno-
stained for MAP2. Results are shown as the mean  SEM of 40–52
cells from two experiments. *** p 0.001 (Student’s t test) compared
with corresponding measurements in 3g8 antibody-treated cells.
Scale bar, 80 m.
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et al., 2004). Other CD3-containing receptors have been
characterized in NK cells that belong to the family of acti-
vating receptors named NKp46, NKp30, and the low-affinity
Fc receptor for IgG (Lanier, 2001). The neuronal expression
of these NK cell–activating receptors has not been reported
so far, and further studies will be required to identify the
nature of the neuronal CD3-associated receptor.
Also critical to understanding how CD3 control neuronal
morphogenesis is identifying downstream signaling. We
have found that mutagenesis of the three ITAMs reproduced
the siRNA phenotype, suggesting that the function of CD3
in normal dendrite development was mediated through an
ITAM-dependent mechanism. The current model of TCR-
CD3 signaling in T-cells assumes that the ITAM phosphor-
ylation of CD3 is a molecular switch that triggers the dock-
ing of SH2-containing signaling molecules such as the
protein tyrosine kinases of the Syk/ZAP-70 family, which
subsequently induces downstream signaling events includ-
ing Ca2 mobilization and activation of the Rho and Ras
pathways (Pitcher and van Oers, 2003; Baniyash, 2004). In
agreement with this, we found that CD3 recruitment by a
CD3 antibody induced an elevation of [Ca2]i in cultured
neurons. The expression of ZAP-70–related tyrosine kinase
in developing neurons (Ishijima et al., 1995; Yoneya et al.,
1998), and the reported role of Syk in neurite outgrowth
(Tsujimura et al., 2001; Gallagher et al., 2007) is compatible
with the notion that Syk/ZAP-70 could be a relevant com-
ponent of the intracellular transduction pathway connecting
CD3 activation and Ca2 mobilization to negatively control
dendritic shaping.
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